Tapering Prednisone in Various Clinical Scenarios

Introduction to Tapering

The American Association for the Study of Liver Diseases recommends tapering prednisone in adults with autoimmune hepatitis by 5 mg every week until 10 mg/day is achieved, then reduce by 2.5 mg/week to 5 mg daily 1
The American College of Rheumatology suggests that patients on prednisone for chronic conditions, such as inflammatory arthritis, require gradual tapering when discontinuing treatment to prevent withdrawal syndrome 2
The British Association of Dermatologists recommends beginning tapering 15 days after disease control in patients with bullous pemphigoid 3

For inflammatory arthritis, the European League Against Rheumatism recommends beginning tapering 2-4 weeks after achieving symptom control, with a tapering schedule based on disease severity 2
For immune-related adverse events, the National Comprehensive Cancer Network suggests tapering steroids over 4-6 weeks once symptoms improve to Grade 1 4
For sarcoidosis, the American Thoracic Society recommends tapering steroids over 2-4 months, depending on response 6

The American Gastroenterological Association recommends reducing the dose by approximately 10-20% every 1-4 weeks depending on total duration of therapy, with slower tapering at lower doses 1
The American College of Rheumatology suggests monitoring patients for signs of disease recurrence or adrenal insufficiency during tapering, with regular clinical assessment and inflammatory markers every 4-6 weeks 2
For patients at risk of adrenal insufficiency, the Endocrine Society recommends considering ACTH stimulation testing, particularly after long-term use, although this is not always cited in the context of tapering 1

The American Academy of Pediatrics recommends careful tapering in children to minimize adverse effects, such as growth suppression 1
The Society for Pediatric Dermatology suggests that children with autoimmune hepatitis require tapering over 6-8 weeks to 0.1-0.2 mg/kg daily or 5 mg daily 1